Skip to main content

Unruhe und Ungewissheit: Stem Cells and Risks

  • Chapter
Translational Stem Cell Research

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

This paper focuses on the risk of unknown and uncertain long-term effects of stem cell research and its applications. Research on human embryonic stem cells and induced pluripotent stem cells are used as examples. We discuss some problems that such uncertain knowledge creates for decision makers, and describe how difficult decision making in this context really is. A method for handling this type of hard choice situations is presented and discussed.

The authors wish to thank Anders Castor, Göran Hermerén, Mattias Höglund and Jan Wahlström for constructive comments and help.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Of course, uncertainties emerge from the fact that the fibroblasts are grown in vitro; ordinary cells live under completely different environmental pressures.

  2. 2.

    Those of us looking at this research area from without wonder why tailor-made differentiated cells are not the best alternative if we wish to avoid uncertainties, i.e., by way, not of inducing uncertainty, but blocking combinatorial possibilities. A multipotent, non-pluripotent, cell does not go off the rails as easily.

References

  1. Brännmark J, Sahlin, N-E. Ethical theory and philosophy of risk: First thoughts. Journal of Risk Research 2008; 11:237–54.

    Article  Google Scholar 

  2. Belmonte JCI, Ellis J, Hochedlinger K, Yamanaka S. Viewpoint: Induced pluripotent stem cells and reprogramming: Seeing the science through the hype. Nature 2009; 10:878–83.

    Google Scholar 

  3. Induced Pluripotent Stem Cells, Wikipedia.

    Google Scholar 

  4. Castor A. Stem and progenitor cell involvement in acute lymphoblastic leukemia. Lund University, Faculty of Medicine doctoral dissertation series, Lund 2007: 59.

    Google Scholar 

  5. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315–22.

    Article  PubMed  CAS  Google Scholar 

  6. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human-induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genetics 2009; 41:1350–4.

    Article  PubMed  CAS  Google Scholar 

  7. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5:111–23.

    Article  PubMed  CAS  Google Scholar 

  8. Movassagh M, Choy M-K, Goddard M, Bennett MR, Down TA, et al. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 2010; 5:e8564. doi: 10.1371.

    Article  PubMed  Google Scholar 

  9. Sahlin N-E, Persson J. Epistemic risk: The significance of knowing what one does not know. In: Brehmer, B, Sahlin, N-E (Eds). Future risks and risk management. Dordrecht: Kluwer. 1994, pp. 37–62.

    Chapter  Google Scholar 

  10. Kahneman D, Wakker, P, Sarin, R. Back to Bentham: Explorations of experienced utility. The Quarterly Journal of Economics 1997; 112:375–405.

    Article  Google Scholar 

  11. Frederick S, Loewenstein G. Hedonic adaptation. In: Kahneman D, et al. (Eds). Well-being: The foundations of hedonic psychology. New York: Russell Sage Foundation. 1999: pp. 302–29.

    Google Scholar 

  12. Tyc V. Psychological adaptation of children and adolescents with limb deficiencies: A review. Clinical Psychological Review 1992; 2:275–91.

    Article  Google Scholar 

  13. Vareman N, Persson J. Why separate risk assessors and risk managers? Further external values affecting the risk assessor qua risk assessor. Journal of Risk Research 2010; 13:687–700.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Sahlin, NE., Persson, J., Vareman, N. (2011). Unruhe und Ungewissheit: Stem Cells and Risks. In: Hug, K., Hermerén, G. (eds) Translational Stem Cell Research. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-959-8_30

Download citation

Publish with us

Policies and ethics